...
首页> 外文期刊>European Journal of Lipid Science and Technology >Nanoparticle structure development in the gastro-intestinal model fluid FaSSIF_(mod6.5) from several phospholipids at various water content relevant for oral drug administration
【24h】

Nanoparticle structure development in the gastro-intestinal model fluid FaSSIF_(mod6.5) from several phospholipids at various water content relevant for oral drug administration

机译:胃肠道模型液体FaSSIF_(mod6.5)中与口服给药有关的多种水分下的几种磷脂的纳米结构发展

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The characteristics of intestinal model fluids were investigated at conditions which simulate the passage from the middle to the end of the duodenum. The formation and decay of liposomes and micelles in model bile fluids were studied, because of their role as an intermediate host for the resolution and uptake of hydrophobic drugs (BCS classes II, IV). The conditions, which may influence the formation of these nanoparticulate intermediates were studied, i.e., the lipid composition of the bile, the preparation method, the time of the passage through the modelled duodenum segment and the concentration, which results from the variable dilution of the bile by mixing with the transfer medium representing the fluid arriving from the stomach. The variation of the lecithin entity revealed an equivalence of egg-lecithin of a high purity (99%) with its main component 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine POPC, while 1,2-di-oleoyl-sn-glycero-3-phosphocholine DOPC resulted in a slight delay of the micelle-liposome conversion. The FeSSIF preparation method was best with the sequential-film method, while the bile-film method yielded comparable results; the shake method showed a slightly different kinetics of the nanoparticle conversion. The time and concentration dependence of the formation and decay of lipidic nanoparticles indicates that these strongly depend on the passage time (speed) and bile dilution rate. The corresponding physiological conditions in healthy persons may vary in vivo individually and due to diseases. The studied conditions cover typical physiological conditions, which should be taken into consideration in the exploration of in vitro tests of formulations of hydrophobic drugs.
机译:在模拟从十二指肠中部到末端通过的条件下研究了肠道模型液体的特性。研究了脂质体和胶束在模型胆汁中的形成和衰变,因为它们是分解和吸收疏水性药物(BCS II,IV类)的中间宿主。研究了可能影响这些纳米微粒中间体形成的条件,即胆汁的脂质组成,制备方法,通过建模的十二指肠节段的时间和浓度,这是由于胆汁的可变稀释而产生的。胆汁与代表胃液的传输介质混合。卵磷脂实体的变异揭示了高纯度的卵磷脂(99%)与其主要成分1-棕榈酰-2-油酰-sn-甘油-3-磷酸胆碱POPC等价,而1,2-二油酰-sn-甘油-3-磷酸胆碱DOPC导致胶束-脂质体转化略有延迟。 FeSSIF的制备方法最好采用连续膜法,而胆汁膜法则可比较。摇动法显示出纳米颗粒转化动力学略有不同。脂质纳米颗粒的形成和衰变的时间和浓度依赖性表明,这些强烈依赖于通过时间(速度)和胆汁稀释率。健康人的相应生理状况可能会因疾病而在体内单独发生变化。研究条件涵盖典型的生理条件,在探索疏水性药物制剂的体外测试时应考虑这些条件。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号